Literature DB >> 479637

HLA-linked genes and leprosy: a family study in Karigiri, South India.

P E Fine, E Wolf, J Pritchard, B Watson, D J Bradley, H Festenstein, C J Chacko.   

Abstract

The evidence for a genetic determination of susceptibility to leprosy is reviewed. To test the hypothesis that an HLA (histocompatibility leukocyte antigen)-linked gene is associated with such susceptibility, the association between the distribution of leprosy within a family and the segregation of HLA haplotypes was investigated among 72 families who lived in Karigiri, Tamil Nadu State, South India. A statistically significant association was found for families in which siblings had tuberculoid leprosy and in which neither parent had leprosy. The findings from the data of this study agree with those of two previous studies carried out among smaller populations is Surinam and Wardha, Maharashtra State, India. Such an agreement suggests that a genetic determinant which is linked to the major HLA locus on chromosome 6 and which is probably recessive affects susceptibility to tuberculoid leprosy in humans.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479637     DOI: 10.1093/infdis/140.2.152

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

Review 1.  Human leukocyte antigens (HLA) and mycobacterial disease.

Authors:  R R de Vries; T H Ottenhoff; W C van Schooten
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Genetic epidemiology of the susceptibility to leprosy.

Authors:  E D Shields; D A Russell; M A Pericak-Vance
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

Review 3.  Human genetics of common mycobacterial infections.

Authors:  Natascha Remus; Alexandre Alcaïs; Laurent Abel
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins.

Authors:  W van Eden; R R de Vries; J L Stanford; G A Rook
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.